Connection
Jennifer Dotson to Gastrointestinal Agents
This is a "connection" page, showing publications Jennifer Dotson has written about Gastrointestinal Agents.
|
|
Connection Strength |
|
 |
|
 |
|
2.180 |
|
|
|
-
Gupta SR, Bricker J, Boyle BM, Maltz RM, Michel HK, Dotson JL. Outcomes for Standardized Home and Hospital-Based Infusions of Infliximab for Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2023 06 01; 76(6):776-781.
Score: 0.802
-
Gupta SR, Crandall WV, Donegan A, Johnson M, Drobnic B, Oates M, Boyle B, Maltz RM, Dotson JL. A Quality Improvement Approach to External Infliximab Infusions in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2019 11; 69(5):544-550.
Score: 0.635
-
Dotson JL, Nwomeh B, Andridge R, Anderson SE, Crandall WV. Variation in management of intra-abdominal abscesses in children with Crohn's disease. Inflamm Bowel Dis. 2013 Mar-Apr; 19(4):818-25.
Score: 0.400
-
Davidson N, Morris GA, Wright MA, Brock G, Boyle B, Dotson JL, Michel HK, Maltz RM. Predictors of antitumor necrosis factor primary nonresponse and drug durability in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2025 Oct; 81(4):1024-1033.
Score: 0.236
-
McNicol M, Abdel-Rasoul M, McClinchie MG, Morris GA, Boyle B, Dotson JL, Michel HK, Maltz RM. Clinical outcomes and cost savings of a nonmedical switch to a biosimilar in children/young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 03; 78(3):644-652.
Score: 0.053
-
Rowland P, McNicol M, Kiel A, Maltz RM, Donegan A, Dotson JL, Michel HK, Boyle B. Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 Apr; 78(4):853-861.
Score: 0.053
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|